Rhumbline Advisers Sells 44,720 Shares of Azenta, Inc. (NASDAQ:AZTA)

Rhumbline Advisers lessened its holdings in Azenta, Inc. (NASDAQ:AZTA) by 28.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 111,653 shares of the company’s stock after selling 44,720 shares during the period. Rhumbline Advisers owned 0.24% of Azenta worth $5,583,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of AZTA. Farther Finance Advisors LLC lifted its position in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares during the last quarter. KBC Group NV grew its stake in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after acquiring an additional 698 shares during the last quarter. Assenagon Asset Management S.A. bought a new position in Azenta during the fourth quarter worth $200,000. Aigen Investment Management LP bought a new stake in Azenta in the 3rd quarter valued at $214,000. Finally, Empowered Funds LLC bought a new position in shares of Azenta during the 4th quarter worth about $293,000. 99.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on AZTA. Needham & Company LLC lifted their target price on shares of Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th. Evercore ISI boosted their price target on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Finally, Stephens reaffirmed an “overweight” rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd.

Azenta Stock Performance

AZTA opened at $42.94 on Friday. The firm has a market capitalization of $1.96 billion, a PE ratio of -14.41 and a beta of 1.47. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $67.77. The business’s 50-day simple moving average is $50.30 and its 200 day simple moving average is $47.83.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.